San Diego Business Journal

Recent Stories

Funding Strategy Brings Potential $10M to Dermata

Local biotech Dermata Therapeutics LLC is bringing in $10 million to fuel the development of its dermatological products, the company announced Feb. 16.

Dauntless Enters the Clinic With Extra $25 Million

Dauntless Pharmaceuticals, a San Diego biotech with an innovative business model, scored an additional $25 million to enter the clinic with its first investigational drug.

Tease photo

Software Startup Partners With Samsung

Software startup Urban Translations has scored a partnership with Samsung Electronics that could set the San Diego company on a path for growth.

Biocept Hires Ex-Trovagene Executive Michael Terry

Liquid biopsy company Biocept Inc. has hired ex-Trovagene executive Michael Terry to join their leadership team as senior vice president of commercial operations.

Local Angels Shore Up Risk With These Strategies

STARTUPS: Investors Share Advice on Maximizing Gamble

Like amateur traders in the stock market (expecting to win big on the next unicorn), nascent investors often imagine that angel investing will be their lottery ticket to wealth.

Ionis Earns $75 Million from Bayer

Carlsbad drugmaker Ionis Pharmaceuticals Inc. is receiving a $75 million payment from its partner Bayer to advance two anti-blood-clotting programs.

Retrophin Brings on Ex-Ardea Executive to Lead R&D

Local biotech Retrophin Inc. has hired William “Bill” Rote as senior vice president of research and development.

NuVasive Posts Record Revenue of $962.1 Million for 2016

Local medical device maker NuVasive Inc. reported strong financial performance for 2016, indicating good times are ahead for 2017.

Illumina Adds Three Startups to Accelerator Program

Local science technology company Illumina Inc. has added three new startups to its accelerator program, which mentors and invests money into early-stage companies in the genomics technology space.

Tease photo

Vividion’s Backers Give It Good Starting Point With $50M

BIOTECH: Spun Out of TSRI, Co.’s Biotech to Tap Genetic Advances

A recent infusion of cash launched a local biotech out of stealth mode with the biggest VC backing of the year so far in San Diego.

More stories